Ethifarmsp. z o.o.

Wholesale of pharmaceutical, medical and orthopaedic goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2004-03-15
Share capital
100 000,00 PLN
Activity description

Ethifarm Sp. z o.o. is a pharmaceutical company founded in 2004, carrying out development and implementation work and registering medicinal products and dietary supplements. It works with partners in Poland and abroad on product development, implementation and technology transfer.

Registered address
Hiacyntowa 39, 60-175 Poznań, Poland
Website
ethifarm.plWebsite active
Electronic delivery address
AE:PL-65471-96232-FJIWS-18

Financials

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 14.54kMedianUSD 59.87kAverageUSD 4.37m
Net profit
This companyUSD -74.56kMedianUSD -21.45kAverageUSD 90.81k
Operating costs
This companyUSD 89.08kMedianUSD 89.34kAverageUSD 4.11m
Assets
This companyUSD 94.80kMedianUSD 487.30kAverageUSD 2.57m

Bank accounts

Registered as a VAT taxpayer on 2000-04-28. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

7 public aid cases recorded, with a total value of $13,681.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,282
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$392
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$395

Tenders

No recorded participation in tenders.

Trademarks

Ethifarm holds 1 active trademark registered with the Polish Patent Office. 6 marks have expired or were not registered. The first mark was filed in 2004.

MarkProtected until
DIOSMINAL(word)Jan 6, 2030
MAGPerine(word)–
Diosmin 300 ETHIFARM(word)–
Diosmin 500 ETHIFARM(word)–
CARDIO - PROTECTIN(word)–

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Authorized Representatives

Piotr Igor Czakłosz – President of the Management Board
Joanna Eliza Namiota – Attorney-in-fact (sole)

Manner of representation

To make declarations of will concerning the company’s property and non-property rights and obligations and to sign documents on behalf of the company, each member of the management board is authorized to act independently.

Ownership

OwnerSharesShare valueStake
Piotr Igor Czakłosz (61)
500$13,506.2150%
Krzysztof Robiński (66)
500$13,506.2150%

Beneficial owners

Person

Competitors

Name
IXA Solutionssp. z o.o.
Keslosp. z o.o.
AS Comfort & Trendssp. z o.o.
Apollo Electronicssp. z o.o.
Skyraiderssp. z o.o.
FLY Groupsp. z o.o.
Skydive Polska.Plsp. z o.o.
LotairS.A.
Baltipolsp. z o.o.
Alioth Intelligencesp. z o.o.

FAQ

Last updated: 2026-10-07